Register
Login:
Share:
Email Facebook Twitter

PHARMA: Heat Biologics - a 'potentially transformative' lung cancer treatment, Phase II data Q3 2018 Watch here

Looking for big risk, big reward investing? See our exclusive Pharma video series from 'Biotech and Money'


Rolls Royce Broker Ratings



Broker Ratings for Rolls Royce (RR.)


Share Price: 888.50Bid: 977.50Ask: 844.50Change: -2.50 (-0.28%)Faller - Rolls-royce Hlg
Spread: -133.00Spread as %: -13.61%Open: 891.00High: 899.00Low: 888.00Yesterday’s Close: 891.00


Broker Recommendations for Rolls Royce (RR.)
DateBrokerRatingOld TargetNew TargetChange
08-Nov-17BarclaysUnderweight600.00670.00Reiteration
09-Aug-17Berenberg BankHold770.00990.00Reiteration
02-Aug-17DeutscheSell-570.00Reiteration
01-Aug-17CitigroupBuy-1,137.00Reiteration
21-Jul-17CitigroupBuy-1,137.00Reiteration
11-Jul-17Credit SuisseUnderperform-665.00Reiteration
05-Jul-17JefferiesBuy900.001,100.00Reiteration
05-Jul-17JP Morgan CazenoveNeutral780.00950.00Reiteration
05-May-17CitigroupBuy-912.00Reiteration
05-May-17Goldman SachsBuy-1,037.00Reiteration
06-Apr-17Credit SuisseUnderperform595.00665.00Reiteration
29-Mar-17DeutscheSell475.00540.00Reiteration
24-Mar-17JP Morgan CazenoveNeutral740.00780.00Reiteration
15-Feb-17UBSBuy835.00835.00Reiteration
08-Feb-17JP Morgan CazenoveNeutral730.00740.00Reiteration


Registered members see more Rolls Royce broker ratings!
Sign up here for your free account.




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.